{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:24:21Z","timestamp":1792441461790,"version":"4.5.0"},"reference-count":70,"publisher":"American Association for the Advancement of Science (AAAS)","issue":"792","content-domain":{"domain":["www.science.org"],"crossmark-restriction":true},"short-container-title":["Sci. Transl. Med."],"published-print":{"date-parts":[[2025,4,2]]},"abstract":"<jats:p>\n            The number of patients requiring dialysis therapy continues to increase worldwide because of the lack of effective treatments for chronic kidney disease (CKD). Furthermore, no curative treatments for acute kidney injury (AKI) have been established. The therapeutic effects of human induced pluripotent stem cell\u2013derived nephron progenitor cells (hiPSC-NPCs) on AKI have been reported in mice but not clinically confirmed. There are also no reports examining the therapeutic potential of hiPSC-NPCs on CKD. Although large numbers of uniform hiPSC-NPCs are required for cell therapies for AKI and CKD, effective expansion cultures remain to be developed. Here, we established a culture medium for cells that enabled more than 100-fold proliferation of hiPSC-NPCs from multiple hiPSC lines in two passages. We demonstrated that hiPSC-NPCs expanded by our medium named CFY or by their conditioned medium alone attenuated kidney injury and improved survival in cisplatin-induced AKI mice. We also observed that hiPSC-NPCs prevented kidney functional decline, interstitial fibrosis, and senescence in aristolochic acid\u2013induced CKD mice. In addition, we found c-MET to be a specific cell surface marker for hiPSC-NPCs and confirmed that purified c-MET\n            <jats:sup>+<\/jats:sup>\n            hiPSC-NPCs had therapeutic effects on AKI and CKD mice. Furthermore, we found that hiPSC-NPCs exerted their therapeutic effects in AKI and CKD mice by secreting vascular endothelial growth factor A. Expanded hiPSC-NPCs may be useful cell therapies for AKI and CKD and may open avenues for treating kidney diseases.\n          <\/jats:p>","DOI":"10.1126\/scitranslmed.adt5553","type":"journal-article","created":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T20:32:02Z","timestamp":1743625922000},"update-policy":"https:\/\/doi.org\/10.34133\/aaas_crossmark","source":"Crossref","is-referenced-by-count":20,"title":["Human iPSC\u2013derived nephron progenitor cells treat acute kidney injury and chronic kidney disease in mouse models"],"prefix":"10.1126","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9101-9417","authenticated-orcid":true,"given":"Toshikazu","family":"Araoka","sequence":"first","affiliation":[{"name":"Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto 606-8507, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2229-004X","authenticated-orcid":true,"given":"Kosuke","family":"Toyohara","sequence":"additional","affiliation":[{"name":"Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto 606-8507, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8615-6318","authenticated-orcid":true,"given":"Makoto","family":"Ryosaka","sequence":"additional","affiliation":[{"name":"Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto 606-8507, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chihiro","family":"Inui","sequence":"additional","affiliation":[{"name":"Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto 606-8507, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maasa","family":"Matsuura","sequence":"additional","affiliation":[{"name":"Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto 606-8507, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1569-4987","authenticated-orcid":true,"given":"Chen","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Micro Engineering, Kyoto University, Kyoto 615-8540, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3123-6542","authenticated-orcid":true,"given":"Jun","family":"Watahiki","sequence":"additional","affiliation":[{"name":"Medical Innovation Center (MIC), Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongwei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Biology and Regenerative Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2085-732X","authenticated-orcid":true,"given":"Mio","family":"Iwasaki","sequence":"additional","affiliation":[{"name":"Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto 606-8507, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4381-4229","authenticated-orcid":true,"given":"Akira","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Medical Innovation Center (MIC), Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6306-2693","authenticated-orcid":true,"given":"Ryuji","family":"Yokokawa","sequence":"additional","affiliation":[{"name":"Department of Micro Engineering, Kyoto University, Kyoto 615-8540, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8974-277X","authenticated-orcid":true,"given":"Yasuhiko","family":"Tabata","sequence":"additional","affiliation":[{"name":"Cell Biotechnology Group, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0557-8875","authenticated-orcid":true,"given":"Juan Carlos","family":"Izpisua Belmonte","sequence":"additional","affiliation":[{"name":"Altos Labs, San Diego, CA 92121, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7238-2763","authenticated-orcid":true,"given":"Kenji","family":"Osafune","sequence":"additional","affiliation":[{"name":"Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto 606-8507, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.164.6.659"},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1093\/ndt\/gfm051","article-title":"Kidney dysfunction as a risk factor for first symptomatic stroke events in a general Japanese population--The Ohasama study","volume":"22","author":"Nakayama M.","year":"2007","unstructured":"M. Nakayama, H. Metoki, H. Terawaki, T. Ohkubo, M. Kikuya, T. Sato, K. Nakayama, K. Asayama, R. Inoue, J. Hashimoto, K. Totsune, H. Hoshi, S. Ito, Y. Imai, Kidney dysfunction as a risk factor for first symptomatic stroke events in a general Japanese population--The Ohasama study. Nephrol. Dial. Transplant. 22, 1910\u20131915 (2007).","journal-title":"Nephrol. Dial. Transplant."},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1053\/j.ajkd.2022.03.011","article-title":"Clinical trial considerations in developing treatments for early stages of common, chronic kidney diseases: A scientific Workshop sosponsored by the National Kidney Foundation and the US Food and Drug Administration","volume":"80","author":"Inker L. A.","year":"2022","unstructured":"L. A. Inker, M. E. Grams, H. Gu\u00f0mundsd\u00f3ttir, P. M. Ewan, R. Friedman, A. Thompson, D. E. Weiner, K. Willis, H. J. L. Heerspink, NKF-FDA Conference on Clinical Trial Considerations in Developing Treatments for Early Stages of Common, Chronic Kidney Diseases Advisory Group, Clinical trial considerations in developing treatments for early stages of common, chronic kidney diseases: A scientific Workshop sosponsored by the National Kidney Foundation and the US Food and Drug Administration. Am. J. Kidney Dis. 80, 513\u2013526 (2022).","journal-title":"Am. J. Kidney Dis."},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2011.379"},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/ki.2013.153","article-title":"Raising awareness of acute kidney injury: A global perspective of a silent killer","volume":"84","author":"Lewington A. J.","year":"2013","unstructured":"A. J. Lewington, J. Cerd\u00e1, R. L. Mehta, Raising awareness of acute kidney injury: A global perspective of a silent killer. Kidney Int. 84, 457\u2013467 (2013).","journal-title":"Kidney Int."},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2016010105"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/aor.13943"},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1681\/ASN.2007010044","article-title":"Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomerular adipocytes","volume":"18","author":"Kunter U.","year":"2007","unstructured":"U. Kunter, S. Rong, P. Boor, F. Eitner, G. M\u00fcller-Newen, Z. Djuric, C. R. van Roeyen, A. Konieczny, T. Ostendorf, L. Villa, M. Milovanceva-Popovska, D. Kerjaschki, J. Floege, Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomerular adipocytes. J. Am. Soc. Nephrol. 18, 1754\u20131764 (2007).","journal-title":"J. Am. Soc. Nephrol."},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2014.11.004"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2019.05.084"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature15695"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2013.11.010"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.3392"},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"8826","DOI":"10.1038\/srep08826","article-title":"Renal progenitors derived from human iPSCs engraft and restore function in a mouse model of acute kidney injury","volume":"5","author":"Imberti B.","year":"2015","unstructured":"B. Imberti, S. Tomasoni, O. Ciampi, A. Pezzotta, M. Derosas, C. Xinaris, P. Rizzo, E. Papadimou, R. Novelli, A. Benigni, G. Remuzzi, M. Morigi, Renal progenitors derived from human iPSCs engraft and restore function in a mouse model of acute kidney injury. Sci. Rep. 5, 8826 (2015).","journal-title":"Sci. Rep."},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.5966\/sctm.2014-0219"},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"107476","DOI":"10.1016\/j.celrep.2020.03.040","article-title":"A modular differentiation system maps multiple human kidney lineages from pluripotent stem cells","volume":"31","author":"Tsujimoto H.","year":"2020","unstructured":"H. Tsujimoto, T. Kasahara, S. I. Sueta, T. Araoka, S. Sakamoto, C. Okada, S. I. Mae, T. Nakajima, N. Okamoto, D. Taura, M. Nasu, T. Shimizu, M. Ryosaka, Z. Li, M. Sone, M. Ikeya, A. Watanabe, K. Osafune, A modular differentiation system maps multiple human kidney lineages from pluripotent stem cells. Cell Rep. 31, 107476 (2020).","journal-title":"Cell Rep."},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"6375","DOI":"10.1038\/s41598-018-24714-3","article-title":"Development of new method to enrich human iPSC-derived renal progenitors using cell surface markers","volume":"8","author":"Hoshina A.","year":"2018","unstructured":"A. Hoshina, T. Kawamoto, S. I. Sueta, S. I. Mae, T. Araoka, H. Tanaka, Y. Sato, Y. Yamagishi, K. Osafune, Development of new method to enrich human iPSC-derived renal progenitors using cell surface markers. Sci. Rep. 8, 6375 (2018).","journal-title":"Sci. Rep."},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-018-0253-2"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.devcel.2015.06.021"},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.stemcr.2019.07.003","article-title":"Activin is superior to BMP7 for efficient maintenance of human iPSC-derived nephron progenitors","volume":"13","author":"Tanigawa S.","year":"2019","unstructured":"S. Tanigawa, H. Naganuma, Y. Kaku, T. Era, T. Sakuma, T. Yamamoto, A. Taguchi, R. Nishinakamura, Activin is superior to BMP7 for efficient maintenance of human iPSC-derived nephron progenitors. Stem Cell Rep. 13, 322\u2013337 (2019).","journal-title":"Stem Cell Rep."},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2016.07.016"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2018.10.010"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/bit.260401013"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2018070747"},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1002\/emmm.201201584","article-title":"Identification of human nephron progenitors capable of generation of kidney structures and functional repair of chronic renal disease","volume":"5","author":"Harari-Steinberg O.","year":"2013","unstructured":"O. Harari-Steinberg, S. Metsuyanim, D. Omer, Y. Gnatek, R. Gershon, S. Pri-Chen, D. D. Ozdemir, Y. Lerenthal, T. Noiman, H. Ben-Hur, Z. Vaknin, D. F. Schneider, B. J. Aronow, R. S. Goldstein, P. Hohenstein, B. Dekel, Identification of human nephron progenitors capable of generation of kidney structures and functional repair of chronic renal disease. EMBO Mol. Med. 5, 1556\u20131568 (2013).","journal-title":"EMBO Mol. Med."},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt0708-739"},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"12169","DOI":"10.1038\/s41598-018-30628-x","article-title":"Aristolochic acid I determine the phenotype and activation of macrophages in acute and chronic kidney disease","volume":"8","author":"Honarpisheh M.","year":"2018","unstructured":"M. Honarpisheh, O. Foresto-Neto, S. Steiger, F. Kraft, P. Koehler, E. von Rauchhaupt, J. Potempa, K. Adamowicz, J. Koziel, M. Lech, Aristolochic acid I determine the phenotype and activation of macrophages in acute and chronic kidney disease. Sci. Rep. 8, 12169 (2018).","journal-title":"Sci. Rep."},{"key":"e_1_3_2_29_2","unstructured":"T. F. M. Nangaku Comprehensive Clinical Nephrology (Mosby Elsevier ed. 3 2008) vol. 34."},{"key":"e_1_3_2_30_2","doi-asserted-by":"crossref","first-page":"C126","DOI":"10.1152\/ajpcell.00329.2011","article-title":"Indoxyl sulfate promotes vascular smooth muscle cell senescence with upregulation of p53, p21, and prelamin A through oxidative stress","volume":"303","author":"Muteliefu G.","year":"2012","unstructured":"G. Muteliefu, H. Shimizu, A. Enomoto, F. Nishijima, M. Takahashi, T. Niwa, Indoxyl sulfate promotes vascular smooth muscle cell senescence with upregulation of p53, p21, and prelamin A through oxidative stress. Am. J. Physiol. Cell Physiol. 303, C126\u2013C134 (2012).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nrneph.2013.176","article-title":"Mechanisms of vascular calcification in CKD-evidence for premature ageing?","volume":"9","author":"Shanahan C. M.","year":"2013","unstructured":"C. M. Shanahan, Mechanisms of vascular calcification in CKD-evidence for premature ageing? Nat. Rev. Nephrol. 9, 661\u2013670 (2013).","journal-title":"Nat. Rev. Nephrol."},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0611079104"},{"key":"e_1_3_2_33_2","doi-asserted-by":"crossref","first-page":"770","DOI":"10.3389\/fphar.2019.00770","article-title":"Cellular senescence and the kidney: Potential therapeutic targets and tools","volume":"10","author":"Knoppert S. N.","year":"2019","unstructured":"S. N. Knoppert, F. A. Valentijn, T. Q. Nguyen, R. Goldschmeding, L. L. Falke, Cellular senescence and the kidney: Potential therapeutic targets and tools. Front. Pharmacol. 10, 770 (2019).","journal-title":"Front. Pharmacol."},{"key":"e_1_3_2_34_2","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1177\/0960327119897099","article-title":"Mitochondrial dysfunction is involved in aristolochic acid I-induced apoptosis in renal proximal tubular epithelial cells","volume":"39","author":"Liu X.","year":"2020","unstructured":"X. Liu, J. Wu, J. Wang, X. Feng, H. Wu, R. Huang, J. Fan, X. Yu, X. Yang, Mitochondrial dysfunction is involved in aristolochic acid I-induced apoptosis in renal proximal tubular epithelial cells. Hum. Exp. Toxicol. 39, 673\u2013682 (2020).","journal-title":"Hum. Exp. Toxicol."},{"key":"e_1_3_2_35_2","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S0140-6736(89)92145-4","article-title":"Mitochondrial DNA mutations as an important contributor to ageing and degenerative diseases","volume":"1","author":"Linnane A. W.","year":"1989","unstructured":"A. W. Linnane, S. Marzuki, T. Ozawa, M. Tanaka, Mitochondrial DNA mutations as an important contributor to ageing and degenerative diseases. Lancet 1, 642\u2013645 (1989).","journal-title":"Lancet"},{"key":"e_1_3_2_36_2","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/j.cell.2016.11.052","article-title":"In vivo amelioration of age-associated hallmarks by partial reprogramming","volume":"167","author":"Ocampo A.","unstructured":"A. Ocampo, P. Reddy, P. Martinez-Redondo, A. Platero-Luengo, F. Hatanaka, T. Hishida, M. Li, D. Lam, M. Kurita, E. Beyret, T. Araoka, E. Vazquez-Ferrer, D. Donoso, J. L. Roman, J. Xu, C. Rodriguez Esteban, G. Nu\u00f1ez, E. Nu\u00f1ez Delicado, J. M. Campistol, I. Guillen, P. Guillen, J. C. Izpisua Belmonte, In vivo amelioration of age-associated hallmarks by partial reprogramming. Cell 167, 1719\u20131733.e12 (2016).","journal-title":"Cell"},{"key":"e_1_3_2_37_2","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1111\/j.1582-4934.2008.00641.x","article-title":"VEGF is a mediator of the renoprotective effects of multipotent marrow stromal cells in acute kidney injury","volume":"13","author":"T\u00f6gel F.","year":"2009","unstructured":"F. T\u00f6gel, P. Zhang, Z. Hu, C. Westenfelder, VEGF is a mediator of the renoprotective effects of multipotent marrow stromal cells in acute kidney injury. J. Cell. Mol. Med. 13, 2109\u20132114 (2009).","journal-title":"J. Cell. Mol. Med."},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-0652"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/20.11.2768"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-18568-4"},{"key":"e_1_3_2_41_2","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1681\/ASN.2006121304","article-title":"Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy","volume":"18","author":"Lindenmeyer M. T.","year":"2007","unstructured":"M. T. Lindenmeyer, M. Kretzler, A. Boucherot, S. Berra, Y. Yasuda, A. Henger, F. Eichinger, S. Gaiser, H. Schmid, M. P. Rastaldi, R. W. Schrier, D. Schl\u00f6ndorff, C. D. Cohen, Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy. J. Am. Soc. Nephrol. 18, 1765\u20131776 (2007).","journal-title":"J. Am. Soc. Nephrol."},{"key":"e_1_3_2_42_2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1681\/ASN.V11147","article-title":"Peritubular capillary injury during the progression of experimental glomerulonephritis in rats","volume":"11","author":"Ohashi R.","year":"2000","unstructured":"R. Ohashi, H. Kitamura, N. Yamanaka, Peritubular capillary injury during the progression of experimental glomerulonephritis in rats. J. Am. Soc. Nephrol. 11, 47\u201356 (2000).","journal-title":"J. Am. Soc. Nephrol."},{"key":"e_1_3_2_43_2","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1097\/01.ASN.0000018408.51388.57","article-title":"Peritubular capillary regression during the progression of experimental obstructive nephropathy","volume":"13","author":"Ohashi R.","year":"2002","unstructured":"R. Ohashi, A. Shimizu, Y. Masuda, H. Kitamura, M. Ishizaki, Y. Sugisaki, N. Yamanaka, Peritubular capillary regression during the progression of experimental obstructive nephropathy. J. Am. Soc. Nephrol. 13, 1795\u20131805 (2002).","journal-title":"J. Am. Soc. Nephrol."},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00085.x"},{"key":"e_1_3_2_45_2","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/nrneph.2012.197","article-title":"Subclinical AKI--an emerging syndrome with important consequences","volume":"8","author":"Haase M.","year":"2012","unstructured":"M. Haase, J. A. Kellum, C. Ronco, Subclinical AKI--an emerging syndrome with important consequences. Nat. Rev. Nephrol. 8, 735\u2013739 (2012).","journal-title":"Nat. Rev. Nephrol."},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00275.x"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2013070703"},{"key":"e_1_3_2_48_2","doi-asserted-by":"crossref","first-page":"F1383","DOI":"10.1152\/ajprenal.00366.2019","article-title":"Capillary rarefaction is more closely associated with CKD progression after cisplatin, rhabdomyolysis, and ischemia-reperfusion-induced AKI than renal fibrosis","volume":"317","author":"Menshikh A.","year":"2019","unstructured":"A. Menshikh, L. Scarfe, R. Delgado, C. Finney, Y. Zhu, H. Yang, M. P. de Caestecker, Capillary rarefaction is more closely associated with CKD progression after cisplatin, rhabdomyolysis, and ischemia-reperfusion-induced AKI than renal fibrosis. Am. J. Physiol. Renal Physiol. 317, F1383\u2013F1397 (2019).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"e_1_3_2_49_2","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1161\/CIRCRESAHA.120.317422","article-title":"Erythrocytes a new\/old target for hypoxia in chronic kidney disease?","volume":"127","author":"Gewin L. S.","year":"2020","unstructured":"L. S. Gewin, Erythrocytes a new\/old target for hypoxia in chronic kidney disease? Circ. Res. 127, 376\u2013378 (2020).","journal-title":"Circ. Res."},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1053\/hupa.2000.20373"},{"key":"e_1_3_2_51_2","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1161\/HYPERTENSIONAHA.118.11766","article-title":"Loss of renal peritubular capillaries in hypertensive patients is detectable by urinary endothelial microparticle levels","volume":"72","author":"Sun I. O.","year":"2018","unstructured":"I. O. Sun, A. Santelli, A. Abumoawad, A. Eirin, C. M. Ferguson, J. R. Woollard, A. Lerman, S. C. Textor, A. S. Puranik, L. O. Lerman, Loss of renal peritubular capillaries in hypertensive patients is detectable by urinary endothelial microparticle levels. Hypertension 72, 1180\u20131188 (2018).","journal-title":"Hypertension"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abm6756"},{"key":"e_1_3_2_53_2","doi-asserted-by":"crossref","first-page":"e0123322","DOI":"10.1128\/mbio.01233-22","article-title":"VEGF-mediated augmentation of autophagic and lysosomal activity in endothelial cells defends against intracellular streptococcus pyogenes","volume":"13","author":"Lu S.-L.","year":"2022","unstructured":"S.-L. Lu, H. Omori, Y. Zhou, Y.-S. Lin, C.-C. Liu, J.-J. Wu, T. Noda, VEGF-mediated augmentation of autophagic and lysosomal activity in endothelial cells defends against intracellular streptococcus pyogenes. mBio 13, e0123322 (2022).","journal-title":"mBio"},{"key":"e_1_3_2_54_2","doi-asserted-by":"crossref","first-page":"5286","DOI":"10.1073\/pnas.91.12.5286","article-title":"Epithelial differentiation of metanephric mesenchymal cells after stimulation with hepatocyte growth factor or embryonic spinal cord","volume":"91","author":"Karp S. L.","year":"1994","unstructured":"S. L. Karp, A. Ortiz-Arduan, S. Li, E. G. Neilson, Epithelial differentiation of metanephric mesenchymal cells after stimulation with hepatocyte growth factor or embryonic spinal cord. Proc. Natl. Acad. Sci. U.S.A. 91, 5286\u20135290 (1994).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.1999.79.4.1157"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.298.17.2038"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.87680"},{"key":"e_1_3_2_58_2","first-page":"eaaz8697","article-title":"Extracellular vesicles deposit","volume":"13","author":"Lei Q.","year":"2021","unstructured":"Q. Lei, F. Gao, T. Liu, W. Ren, L. Chen, Y. Cao, W. Chen, S. Guo, Q. Zhang, W. Chen, H. Wang, Z. Chen, Q. Li, Y. Hu, A.-Y. Guo, Extracellular vesicles deposit. Sci. Transl. Med. 13, eaaz8697 (2021).","journal-title":"Sci. Transl. Med."},{"key":"e_1_3_2_59_2","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/jcp.29940","article-title":"Increased cellular senescence in the murine and human stenotic kidney: Effect of mesenchymal stem cells","volume":"236","author":"Kim S. R.","year":"2021","unstructured":"S. R. Kim, X. Zou, H. Tang, A. S. Puranik, A. M. Abumoawad, X. Y. Zhu, L. J. Hickson, T. Tchkonia, S. C. Textor, J. L. Kirkland, L. O. Lerman, Increased cellular senescence in the murine and human stenotic kidney: Effect of mesenchymal stem cells. J. Cell. Physiol. 236, 1332\u20131344 (2021).","journal-title":"J. Cell. Physiol."},{"key":"e_1_3_2_60_2","doi-asserted-by":"crossref","first-page":"173343","DOI":"10.1016\/j.ejphar.2020.173343","article-title":"Human umbilical cord mesenchymal stem cell attenuates renal fibrosis via TGF-\u03b2\/Smad signaling pathways in vivo and in vitro","volume":"883","author":"Yu Y.","year":"2020","unstructured":"Y. Yu, D. Hu, Y. Zhou, H. Xiang, B. Liu, L. Shen, C. Long, X. Liu, T. Lin, D. He, Y. Zhang, T. Xu, D. Zhang, G. Wei, Human umbilical cord mesenchymal stem cell attenuates renal fibrosis via TGF-\u03b2\/Smad signaling pathways in vivo and in vitro. Eur. J. Pharmacol. 883, 173343 (2020).","journal-title":"Eur. J. Pharmacol."},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-019-0325-y"},{"key":"e_1_3_2_62_2","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/s42003-023-04862-7","article-title":"Cells sorted off hiPSC-derived kidney organoids coupled with immortalized cells reliably model the proximal tubule","volume":"6","author":"Banan Sadeghian R.","year":"2023","unstructured":"R. Banan Sadeghian, R. Ueno, Y. Takata, A. Kawakami, C. Ma, T. Araoka, M. Takasato, R. Yokokawa, Cells sorted off hiPSC-derived kidney organoids coupled with immortalized cells reliably model the proximal tubule. Commun. Biol. 6, 483 (2023).","journal-title":"Commun. Biol."},{"key":"e_1_3_2_63_2","doi-asserted-by":"crossref","first-page":"110760","DOI":"10.1016\/j.isci.2024.110760","article-title":"Efficient proximal tubule-on-chip model from hiPSC-derived kidney organoids for functional analysis of renal transporters","volume":"27","author":"Ma C.","year":"2024","unstructured":"C. Ma, R. Banan Sadeghian, R. Negoro, K. Fujimoto, T. Araoka, N. Ishiguro, M. Takasato, R. Yokokawa, Efficient proximal tubule-on-chip model from hiPSC-derived kidney organoids for functional analysis of renal transporters. iScience 27, 110760 (2024).","journal-title":"iScience"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1000475107"},{"key":"e_1_3_2_65_2","doi-asserted-by":"crossref","first-page":"e0275600","DOI":"10.1371\/journal.pone.0275600","article-title":"In vitro methods to ensure absence of residual undifferentiated human induced pluripotent stem cells intermingled in induced nephron progenitor cells","volume":"17","author":"Tsujimoto H.","year":"2022","unstructured":"H. Tsujimoto, N. Katagiri, Y. Ijiri, B. Sasaki, Y. Kobayashi, A. Mima, M. Ryosaka, K. Furuyama, Y. Kawaguchi, K. Osafune, In vitro methods to ensure absence of residual undifferentiated human induced pluripotent stem cells intermingled in induced nephron progenitor cells. PLOS ONE 17, e0275600 (2022).","journal-title":"PLOS ONE"},{"key":"e_1_3_2_66_2","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3727\/000000006783981323","article-title":"Amelioration of diabetes in mice after single-donor islet transplantation using the controlled release of gelatinized FGF-2","volume":"15","author":"Rivas-Carrillo J. D.","year":"2006","unstructured":"J. D. Rivas-Carrillo, N. Navarro-Alvarez, A. Soto-Gutierrez, T. Okitsu, Y. Chen, Y. Tabata, H. Misawa, H. Noguchi, S. Matsumoto, N. Tanaka, N. Kobayashi, Amelioration of diabetes in mice after single-donor islet transplantation using the controlled release of gelatinized FGF-2. Cell Transplant. 15, 939\u2013944 (2006).","journal-title":"Cell Transplant."},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.1038\/srep19111"},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.10.025"},{"key":"e_1_3_2_69_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-020-00998-0"},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-019-0638-x"},{"key":"e_1_3_2_71_2","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.stem.2024.06.012","article-title":"Construction of multilayered small intestine-like tissue by reproducing interstitial flow","volume":"31","author":"Deguchi S.","year":"2024","unstructured":"S. Deguchi, K. Kosugi, N. Takeishi, Y. Watanabe, S. Morimoto, R. Negoro, F. Yokoi, H. Futatsusako, M. Nakajima-Koyama, M. Iwasaki, T. Yamamoto, Y. Kawaguchi, Y.-s. Torisawa, K. Takayama, Construction of multilayered small intestine-like tissue by reproducing interstitial flow. Cell Stem Cell 31, 1315\u20131326.e8 (2024).","journal-title":"Cell Stem Cell"}],"container-title":["Science Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.science.org\/doi\/pdf\/10.1126\/scitranslmed.adt5553","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T20:38:19Z","timestamp":1743626299000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.science.org\/doi\/10.1126\/scitranslmed.adt5553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,2]]},"references-count":70,"journal-issue":{"issue":"792","published-print":{"date-parts":[[2025,4,2]]}},"alternative-id":["10.1126\/scitranslmed.adt5553"],"URL":"https:\/\/doi.org\/10.1126\/scitranslmed.adt5553","relation":{},"ISSN":["1946-6234","1946-6242"],"issn-type":[{"value":"1946-6234","type":"print"},{"value":"1946-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,2]]},"assertion":[{"value":"2024-10-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"eadt5553"}}